GB9021113D0 - New use of macrolide compounds for active oxygen-mediated diseases - Google Patents

New use of macrolide compounds for active oxygen-mediated diseases

Info

Publication number
GB9021113D0
GB9021113D0 GB909021113A GB9021113A GB9021113D0 GB 9021113 D0 GB9021113 D0 GB 9021113D0 GB 909021113 A GB909021113 A GB 909021113A GB 9021113 A GB9021113 A GB 9021113A GB 9021113 D0 GB9021113 D0 GB 9021113D0
Authority
GB
United Kingdom
Prior art keywords
active oxygen
mediated diseases
new use
macrolide compounds
macrolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB909021113A
Other versions
GB2248184A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB9021113A priority Critical patent/GB2248184A/en
Publication of GB9021113D0 publication Critical patent/GB9021113D0/en
Publication of GB2248184A publication Critical patent/GB2248184A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
GB9021113A 1990-09-28 1990-09-28 New use of macrolide compounds for active oxygen-mediated diseases Withdrawn GB2248184A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9021113A GB2248184A (en) 1990-09-28 1990-09-28 New use of macrolide compounds for active oxygen-mediated diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9021113A GB2248184A (en) 1990-09-28 1990-09-28 New use of macrolide compounds for active oxygen-mediated diseases

Publications (2)

Publication Number Publication Date
GB9021113D0 true GB9021113D0 (en) 1990-11-14
GB2248184A GB2248184A (en) 1992-04-01

Family

ID=10682890

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9021113A Withdrawn GB2248184A (en) 1990-09-28 1990-09-28 New use of macrolide compounds for active oxygen-mediated diseases

Country Status (1)

Country Link
GB (1) GB2248184A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9227055D0 (en) * 1992-12-29 1993-02-24 Fujisawa Pharmaceutical Co New use
AT408520B (en) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Pharmaceutical formulations
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
ZA888680B (en) * 1987-11-20 1990-07-25 Magellan Corp Australia Capacitor construction

Also Published As

Publication number Publication date
GB2248184A (en) 1992-04-01

Similar Documents

Publication Publication Date Title
HU9300536D0 (en) Compounds of medical effect
EP0799617A3 (en) Therapeutic agent for neurological diseases
IL105683A0 (en) Ophthalmologic cannula
GB9204354D0 (en) Compounds for medicinal use
ZA957187B (en) Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments
EP0294053A3 (en) Physiologically active agent for agricultural use
AU2806692A (en) Medicament for the treatment of anxiety
GB9021113D0 (en) New use of macrolide compounds for active oxygen-mediated diseases
EP0302263A3 (en) Therapeutic composition for combatting aids
ZA935647B (en) Treatment of sickle cell disease
EP0437744A3 (en) Fungicidal combination of active agents
EP0370673A3 (en) Therapeutic agent for aids
AU8185491A (en) Treatment of disease
ZA936760B (en) Fungicidal combinations of active compounds
NZ250159A (en) Use of furan-3-carboxamides as microbicides
GB9012954D0 (en) New use of macrolide compounds for skin diseases
ZA908278B (en) Fungicidal combinations of active compounds
GB9012956D0 (en) New use of macrolide compounds for respiratory diseases
AU4728893A (en) Use of macrolide compounds for the treatment of skin diseases
GB9012958D0 (en) New use of macrolide compounds for hematic diseases
GB9012955D0 (en) New use of macrolide compounds for eye diseases
GB9012953D0 (en) New use of macrolide compounds for circulatory diseases
GB9012960D0 (en) New use of macrolide compounds for nervous diseases
GB9012957D0 (en) New use of macrolide compounds for bone diseases
GB9012959D0 (en) New use of macrolide compounds for endocrine diseases

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)